Notably, with non-diabetic patients as reference, recent data on patients with acute coronary syndrome demonstrated a similar risk of the net composite endpoint, including cardiovascular death, MI, stroke and major bleeding at 1 year, in diabetic patients not receiving insulin and a significantly higher risk in those on insulin [31]. This evidence concerns the gene INS and acute coronary syndrome.